Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 68.99%
March 31, 2026 78.76%
December 31, 2025 47.15%
September 30, 2025 -148.7%
June 30, 2025 -24.05%
March 31, 2025 39.39%
December 31, 2024 65.64%
September 30, 2024 32.40%
June 30, 2024 51.31%
March 31, 2024 11.76%
December 31, 2023 -7.62%
September 30, 2023 -32.15%
June 30, 2023 31.54%
March 31, 2023 33.19%
December 31, 2022 38.74%
September 30, 2022 2.50%
June 30, 2022 16.71%
March 31, 2022 35.26%
December 31, 2021 18.93%
September 30, 2021 -6.91%
June 30, 2021 53.06%
March 31, 2021 79.19%
December 31, 2020 78.97%
September 30, 2020 24.59%
June 30, 2020 49.78%
Date Value
March 31, 2020 55.46%
December 31, 2019 51.52%
September 30, 2019 76.66%
June 30, 2019 82.56%
March 31, 2019 70.35%
December 31, 2018 67.38%
September 30, 2018 68.83%
June 30, 2018 63.05%
March 31, 2018 50.44%
December 31, 2017 24.49%
September 30, 2017 63.40%
June 30, 2017 78.09%
March 31, 2017 49.11%
December 31, 2016 51.63%
September 30, 2016 63.91%
June 30, 2016 55.60%
March 31, 2016 0.00%
December 31, 2015 0.00%
September 30, 2015 0.00%
June 30, 2015 0.00%
March 31, 2015 0.00%
December 31, 2014 0.00%
September 30, 2014 0.00%
June 30, 2014 0.00%
March 31, 2014 0.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. --
HealthEquity, Inc. 66.06%
SCWorx Corp. 26.95%
Health Catalyst, Inc. 34.67%
Diaceutics Plc --

Gross Profit Margin (Quarterly) Related Metrics